Calumet, INC /DE Form 4 insider transactions

Director Stephen P. Mawer sold 3,655 shares of Calumet Inc. common stock at an average price of $9.29 per share under a pre-arranged 10b5-1 trading plan.

CEO Louis Todd Borgmann reports acquiring restricted stock units in Calumet, Inc.

Gregory J. Morical, SVP and General Counsel of Calumet Inc., reports the acquisition of restricted stock units (RSUs) on March 31, 2025.

David Lunin, EVP CFO of Calumet Inc., reports the acquisition of restricted stock units.

Bruce A. Fleming, EVP at Calumet, Inc., reports the acquisition of restricted stock units.

Director Stephen P. Mawer reported selling 3,655 shares of Calumet Inc. common stock at an average price of $12.88 on March 24, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Gregory J. Morical, SVP and General Counsel of Calumet Inc., reports the acquisition and disposal of company stock and restricted stock units on March 11, 2025.

EVP Bruce A. Fleming of Calumet, Inc. reports the acquisition and disposal of common stock and restricted stock units to cover tax obligations.

Vincent Donargo, Chief Accounting Officer of Calumet Inc., reports the acquisition and disposal of common stock and restricted stock units on March 11, 2025.

Director Stephen P. Mawer reports the disposition of shares to cover tax obligations and the vesting of restricted stock units.

EVP Scott Obermeier reports the vesting of restricted stock units and subsequent tax withholding, resulting in changes to his beneficial ownership of Calumet Inc. stock.

CEO Louis Todd Borgmann reports the acquisition and disposal of Calumet Inc. common stock and restricted stock units on March 11, 2025.

Director Stephen P. Mawer of Calumet Inc. sold 3,655 shares of common stock at an average price of $12.64 on March 6, 2025, under a pre-arranged trading plan.

David Lunin, EVP CFO of Calumet Inc., reports the acquisition of 2,500 shares of common stock at a price of $13.05 per share on March 4, 2025.

Gregory J. Morical, SVP and General Counsel of Calumet Inc., reports the acquisition of 22,766 Restricted Stock Units (RSUs) on February 25, 2025, vesting on February 25, 2028.

Director Paul C. Raymond reports acquisition of restricted stock units in Calumet, Inc.

Director John G. Boss reports acquiring restricted stock units in Calumet Inc.

Director Stephen P. Mawer reports acquiring restricted stock units in Calumet, Inc.

Director Amy M. Schumacher reports acquiring restricted stock units in Calumet, Inc.

Director James S. Carter reports acquiring restricted stock units in Calumet, Inc.

Calumet Inc.'s CEO, Louis Todd Borgmann, was granted 189,472 restricted stock units (RSUs) on February 25, 2025, which will vest on February 25, 2028.

Vincent Donargo, Chief Accounting Officer of Calumet Inc., reports acquisition of 16,632 restricted stock units vesting on February 25, 2028.

EVP of Specialties at Calumet, Inc., Scott Obermeier, reports acquiring 36,748 Restricted Stock Units (RSUs) on February 25, 2025, which vest on February 25, 2028.

Bruce A. Fleming, EVP at Calumet, Inc., reports acquisition of 32,649 restricted stock units vesting on February 25, 2028.

David Lunin, EVP CFO of Calumet Inc., reports the acquisition of 37,463 Restricted Stock Units (RSUs) on February 25, 2025, vesting on February 25, 2028.

Director Stephen Mawer of Calumet Inc. engaged in stock transactions involving the vesting of restricted stock units and the sale of some shares for cash.

Director James S. Carter acquired 66,573 shares of Calumet Inc. common stock through the vesting of restricted stock units.

Director Amy M. Schumacher acquired 55,950 shares of Calumet, Inc. common stock through the vesting of restricted stock units.

Jennifer Straumins, a director of Calumet Inc., sold 37,861 shares of common stock on December 18, 2024, to offset tax obligations incurred from the company's reorganization.

Director James S. Carter of Calumet Inc. reported the vesting of 8,921 restricted stock units, equivalent to common stock shares, on December 4, 2024.